BICO Group AB (publ) (BICO.ST)
SEK 34.84
(5.07%)
SEK 34.84
(5.07%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2022 | 1.83 Billion SEK | 82.64% |
| 2021 | 1 Billion SEK | 512.6% |
| 2020 | 163.61 Million SEK | 79.09% |
| 2019 | 91.36 Million SEK | 130.95% |
| 2018 | 39.55 Million SEK | 213.86% |
| 2017 | 12.6 Million SEK | 0.0% |
| 2016 | - SEK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q2 | 372.2 Million SEK | -4.42% |
| 2023 Q3 | 429.2 Million SEK | 15.31% |
| 2023 Q1 | 389.4 Million SEK | -26.58% |
| 2022 Q3 | 464.6 Million SEK | 5.23% |
| 2022 Q2 | 441.5 Million SEK | 12.03% |
| 2022 Q1 | 394.1 Million SEK | -2.26% |
| 2022 FY | 1.83 Billion SEK | 82.64% |
| 2022 Q4 | 530.4 Million SEK | 14.16% |
| 2021 FY | 1 Billion SEK | 512.6% |
| 2021 Q2 | 228.7 Million SEK | 96.82% |
| 2021 Q3 | 254.2 Million SEK | 11.15% |
| 2021 Q4 | 403.2 Million SEK | 58.62% |
| 2021 Q1 | 116.2 Million SEK | 0.0% |
| 2020 Q1 | 40.48 Million SEK | -6.77% |
| 2020 FY | 163.61 Million SEK | 79.09% |
| 2020 Q2 | 38.35 Million SEK | -5.27% |
| 2020 Q3 | 41.35 Million SEK | 7.82% |
| 2019 Q1 | 19.66 Million SEK | 4.53% |
| 2019 FY | 91.36 Million SEK | 130.95% |
| 2019 Q2 | 25.24 Million SEK | 28.36% |
| 2019 Q4 | 43.42 Million SEK | 57.2% |
| 2019 Q3 | 27.62 Million SEK | 9.44% |
| 2018 Q4 | 18.81 Million SEK | 4.74% |
| 2018 FY | 39.55 Million SEK | 213.86% |
| 2018 Q1 | 6.67 Million SEK | 28.71% |
| 2018 Q2 | 9.33 Million SEK | 39.78% |
| 2018 Q3 | 17.96 Million SEK | 92.47% |
| 2017 Q2 | 3.12 Million SEK | 22.3% |
| 2017 FY | 12.6 Million SEK | 0.0% |
| 2017 Q1 | 2.55 Million SEK | 31.42% |
| 2017 Q4 | 5.18 Million SEK | 3.86% |
| 2017 Q3 | 4.99 Million SEK | 60.06% |
| 2016 Q4 | 1.94 Million SEK | 0.0% |
| 2016 FY | - SEK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acarix AB (publ) | 5.29 Million SEK | -34459.184% |
| ADDvise Group AB (publ) | 300.6 Million SEK | -508.982% |
| ADDvise Group AB (publ) | 300.6 Million SEK | -508.982% |
| Arcoma AB | 11.07 Million SEK | -16435.092% |
| Bactiguard Holding AB (publ) | 139.98 Million SEK | -1207.749% |
| Boule Diagnostics AB (publ) | 249.71 Million SEK | -633.079% |
| CellaVision AB (publ) | 463.04 Million SEK | -295.343% |
| Clinical Laserthermia Systems AB (publ) | 2.99 Million SEK | -60981.081% |
| Chordate Medical Holding AB (publ) | -28.41 Million SEK | 6542.581% |
| C-Rad AB (publ) | 66.01 Million SEK | -2673.006% |
| Duearity AB (publ) | -4.17 Million SEK | 43915.223% |
| Dignitana AB (publ) | 58.97 Million SEK | -3004.238% |
| Episurf Medical AB (publ) | -41.8 Million SEK | 4479.426% |
| Getinge AB (publ) | 13.43 Billion SEK | 86.37% |
| Scandinavian Real Heart AB (Publ) | -50.21 Million SEK | 3745.356% |
| Iconovo AB (publ) | 17.57 Million SEK | -10314.359% |
| Integrum AB (publ) | 690.56 Thousand SEK | -264988.435% |
| Luxbright AB (publ) | -2.79 Million SEK | 65551.597% |
| Mentice AB (publ) | 236.38 Million SEK | -674.428% |
| OssDsign AB (publ) | 83.64 Million SEK | -2088.535% |
| Paxman AB (publ) | 12.61 Million SEK | -14407.846% |
| Promimic AB (publ) | 38.51 Million SEK | -4652.953% |
| Qlife Holding AB (publ) | -50.75 Million SEK | 3706.88% |
| SciBase Holding AB (publ) | 16.03 Million SEK | -11314.853% |
| ScandiDos AB (publ) | 47.55 Million SEK | -3749.437% |
| Sectra AB (publ) | 557.55 Million SEK | -228.327% |
| Sedana Medical AB (publ) | 108.98 Million SEK | -1579.742% |
| Senzime AB (publ) | 8.33 Million SEK | -21852.272% |
| SpectraCure AB (publ) | -9.22 Million SEK | 19948.206% |
| Stille AB | 132.17 Million SEK | -1285.024% |
| Vitrolife AB (publ) | 1.97 Billion SEK | 7.452% |
| Xvivo Perfusion AB (publ) | 416.91 Million SEK | -339.084% |